Health News Releases

  • Today May 3
October 31, 2023 16:25
ReNAgade Therapeutics to Present Preclinical Data Demonstrating Potent Extra-Hepatic Delivery of mRNA Using Proprietary Lipid Nanoparticles at 11th International mRNA Health Conference
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced it will present preclinical data demonstrating novel and proprietary lipid nanoparticle (LNP)-base
Danny Bar-Zohar, Global Head of Research & Development and Chief Medical Officer for the Healthcare
October 30, 2023 17:37
Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate
Merck, a leading science and technology company, today announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Hengrui). The partnership includes an exclusive license worldw
October 29, 2023 12:30
United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws
Masimo (https://www.masimo.com/)(NASDAQ: MASI) today announced that the United States International Trade Commission (USITC) has recommended a limited exclusion order for infringing Apple Watches with
October 27, 2023 17:27
Boehringer Ingelheim’s SPEVIGO® (spesolimab) wins 2023 Prix Galien USA Best Orphan/Rare Diseases Solution Award
Boehringer Ingelheim today announced that SPEVIGO® (spesolimab) has been recognized as Best Orphan/Rare Diseases Solution of 2023 by the Galien Foundation. The Prix Galien USA Award was presented last
October 27, 2023 16:50
GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally
GC Aesthetics®, a long-established brand in breast aesthetics, and Bimini Health Tech (“Bimini”), a pioneer in healthcare solutions, are pleased to announce their groundbreaking Joint Venture partners
October 27, 2023 11:40
Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the first half of fiscal year 2023 (six months ended September 30, 2023), updating reported and Core forecasts and reconfirming Manag
October 26, 2023 14:25
Galderma Phase III Data Published in the New England Journal of Medicine: Full OLYMPIA 2 Trial Results Demonstrate Nemolizumab’s Rapid Onset of Action in Prurigo Nodularis Patients
Galderma today announced that the New England Journal of Medicine has published full results from the phase III OLYMPIA 2 trial evaluating the efficacy and safety of nemolizumab monotherapy in adults
October 26, 2023 14:10
EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis
EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology uses the power of enzymes to create sustainable products and processes for a variety of industries, announced that it had
October 24, 2023 16:25
Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2
Iksuda Therapeutics (Iksuda), the developer of class leading antibody drug conjugates (ADCs) with enhanced tumour specificity, today announces that the first patient has completed a first cycle of the
October 24, 2023 09:00
ImmuneOncia Announces Positive Phase 1a Results of CD47 Monoclonal Antibody IMC-002 in Solid Tumors at ESMO 2023
ImmuneOncia (http://www.immuneoncia.com/immun/) (CEO Heung Tae Kim) announced the results of its Phase 1a solid tumour clinical trial (IMC-002-K102 Study) of IMC-002, a CD47 monoclonal antibody, at th
Bringing together, all stakeholders involved in research on physical, chemical, and biological realm
October 20, 2023 16:50
Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting.
Harshavardhan Sai Sadineni and Srived Meda of Kasturba Medical College, Manipal, India, won the XVIII Fujio Cup Quiz (FCQ) on Stem cells and Regenerative medicine (RM) in the NCRM NICHE 2023; Sri Rama
October 20, 2023 15:30
Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
Aldena Therapeutics, a private biotech company pioneering siRNA- based therapies for dermatological indications, has chosen PCI Pharma Services (PCI) (https://pci.com/drug-development-manufacturing-se
The new UVDI-GO UV LED Surface Sanitizer inactivates C. difficile spores in only 20 seconds from 4"
October 20, 2023 10:20
New UVDI-GO™ UV LED Surface Sanitizer Inactivates High-Risk Microorganisms in 20 Seconds or Less
UltraViolet Devices, Inc. (UVDI), a leading manufacturer of advanced UV-C disinfection technology, announced today that the new UVDI-GO™ UV LED Surface Sanitizer is now available for use in healthcare
October 20, 2023 09:30
ViiV Healthcare to present 23 abstracts from innovative HIV treatment and prevention portfolio at EACS 2023
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of key abstracts highlighting the breadth of its ap
October 19, 2023 10:55
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.takeda.com&esheet=53633640&newsitemid=20231018884948&lan=en-US&anchor=Takeda&index=1&md5=4152f7bcff17087740131abae020a992)
October 18, 2023 15:30
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
Takeda (TSE:4502/NYSE: TAK) today announced that the Phase 3 ADMIRE-CD II study, assessing the efficacy and safety of Alofisel® (darvadstrocel) for the treatment of complex Crohn’s Perianal Fistulas (
October 18, 2023 14:54
Takeda Settles Tax Dispute with Irish Revenue over Break Fee Received by Shire
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=53624835&newsitemid=20231017233540&lan=en-US&anchor=TSE%3A4502%2FNYSE%
An illustrative summary of the research outcome with Neu REFIX Beta glucan presents, several “Firsts
October 18, 2023 14:50
Neu REFIX β-glucan reduces muscle fibrosis in Duchenne muscular dystrophy MDX mice, in joint research with Dr. Yoshitsugu Aoki, NCNP, Tokyo, Japan.
Skeletal muscle fibrosis which leads to locomotor dysfunction in Duchenne Muscular Dystrophy (DMD) could be significantly reduced by oral consumption of Neu-REFIX beta 1,3-1,6 glucans alone for 45 day
October 18, 2023 10:10
Avania Bolsters MedTech CRO Value Chain Capabilities With Two Acquisitions in Highly Strategic Areas of Engineering Design & Product Development and Market Access
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=53617459&newsitemid=20231017266904&lan=en-US&anchor=Avania&index=1&md5=37cd0200f76b717153750b
October 18, 2023 09:00
Sanofi Bridging the Gap between the Homeless and Society via Futsal
Sanofi in Korea, the Korean subsidiaries of the global healthcare company Sanofi, hosted the founding ceremony of the homeless futsal club ‘Dream’ together with Dalpengyee, a nonprofit organization, t
October 17, 2023 15:55
MMI Expands Global Footprint with Entry into Asia Pacific Market
MMI, (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it will c
October 16, 2023 15:35
Merck to Present Latest Research from Oncology Portfolio at ESMO 2023
Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research on the company’s oncology portfolio addressing unmet needs across bladder, head and nec
October 15, 2023 12:01
Medisca Takes Additional Steps to Protect Its Innovative Technologies
Medisca has taken another step in protecting the strategic research and development (R&D) investments made decades ago that ultimately led to the industry-leading Medisca MAZ® mixer. The Medisca MAZ m
October 15, 2023 11:32
Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) confirmed
Copyrights - Sylvain Granjon
October 15, 2023 11:11
Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event
Galderma, the emerging pure-play dermatology category leader, today hosts the first edition of its Liquid Live event in Dubai as a chance to discuss with clinicians the future of innovation in the fie
25 per page50 per page75 per page100 per page